Career history of Carl Walkey
Former positions of Carl Walkey
| Companies | Position | Start | End |
|---|---|---|---|
| NEUROGENE INC. | Founder | 30/11/2003 | 30/11/2022 |
| Corporate Officer/Principal | 30/11/2003 | 30/11/2022 | |
| Ansible Marketing, Inc. | Founder | 31/12/2013 | - |
Training of Carl Walkey
| University of Toronto | Doctorate Degree |
Statistics
International
| Canada | 3 |
| United States | 2 |
Operational
| Founder | 2 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sectoral
| Consumer Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Neoleukin Therapeutics, Inc.
 Neoleukin Therapeutics, Inc. BiotechnologyHealth Technology Neoleukin Therapeutics, Inc. operates as a biopharmaceutical company, which computational methods to design de novo protein therapeutics. The firm address significant medical needs in oncology, inflammation, and autoimmunity. Its lead product candidate, NL-201, is a combined IL-2 and IL-15 agonist designed to eliminate alpha receptor binding. The company was founded by Daniel-Adriano Silva, Carl Walkey, and Umut Ulge in December 2003 and is headquartered in Seattle, WA. | Health Technology |
| Ansible Marketing, Inc. |
- Stock Market
- Insiders
- Carl Walkey
- Experience
